ROPINIROLE HYDROCHLORIDE

ROPINIROLE HYDROCHLORIDE was reported 3674 times

ROPINIROLE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GENERALISED ONSET NON-MOTOR SEIZURE 4 0.1212
1 DOPAMINE AGONIST WITHDRAWAL SYNDROME 5 0.0926
2 RESTLESS LEG AUGMENTATION SYNDROME 11 0.0710
3 DYSKINESIA HYPERPYREXIA SYNDROME 3 0.0638
4 PARKINSONISM HYPERPYREXIA SYNDROME 6 0.0335
5 JEALOUS DELUSION 8 0.0283
6 CAMPTOCORMIA 6 0.0250
7 DOPAMINE DYSREGULATION SYNDROME 10 0.0224
8 PARKINSONIAN REST TREMOR 4 0.0212
9 DROPPED HEAD SYNDROME 6 0.0152
10 GAMBLING 16 0.0137
11 SUDDEN ONSET OF SLEEP 18 0.0130
12 IMPULSE-CONTROL DISORDER 22 0.0107
13 SLEEP ATTACKS 5 0.0105
14 INFUSION SITE DISCHARGE 18 0.0103
15 INFUSION SITE CELLULITIS 5 0.0095
16 GENITAL DISCOMFORT 5 0.0090
17 SALIVA DISCOLOURATION 3 0.0090
18 INFUSION SITE ABSCESS 4 0.0079
19 PHYSIOTHERAPY 4 0.0078
20 HYPERSEXUALITY 13 0.0071
21 PATHOLOGICAL GAMBLING 11 0.0066
22 FULL BLOOD COUNT ABNORMAL 70 0.0066
23 HALLUCINATIONS, MIXED 27 0.0064
24 PARKINSONIAN GAIT 4 0.0064
25 STOMA SITE HYPERGRANULATION 4 0.0063
26 COMPULSIONS 4 0.0060
27 COMPULSIVE SHOPPING 12 0.0058
28 INFUSION SITE WARMTH 7 0.0057
29 STEREOTYPY 5 0.0053
30 ON AND OFF PHENOMENON 29 0.0052
31 DEEP BRAIN STIMULATION 3 0.0050
32 RESTLESS LEGS SYNDROME 90 0.0049
33 AKINESIA 10 0.0048
34 STOMA SITE PAIN 7 0.0048
35 CRANIOFACIAL FRACTURE 4 0.0047
36 INFUSION SITE MASS 5 0.0046
37 HEAT ILLNESS 3 0.0044
38 GAMBLING DISORDER 12 0.0044
39 MOANING 5 0.0044
40 INFUSION SITE REACTION 13 0.0043
41 BODY TEMPERATURE ABNORMAL 8 0.0043
42 PRODUCT ADMINISTRATION INTERRUPTED 34 0.0043
43 INTUSSUSCEPTION 4 0.0042
44 DENTAL RESTORATION FAILURE 3 0.0042
45 SLEEP TALKING 7 0.0041
46 POLYP 27 0.0041
47 SLOW SPEECH 10 0.0041
48 ANAEMIA VITAMIN B12 DEFICIENCY 2 0.0040
49 ALLERGIC REACTION TO EXCIPIENT 8 0.0040
50 DROWNING 4 0.0040
51 REDUCED FACIAL EXPRESSION 4 0.0039
52 TEETH BRITTLE 4 0.0038
53 FREEZING PHENOMENON 14 0.0038
54 BINGE EATING 4 0.0037
55 COMPULSIVE SEXUAL BEHAVIOUR 3 0.0037
56 STOMA SITE DISCHARGE 10 0.0036
57 INFUSION SITE RASH 5 0.0036
58 INFUSION SITE INFECTION 8 0.0034
59 INFUSION SITE DISCOLOURATION 3 0.0034
60 INFUSION SITE INDURATION 5 0.0034
61 ORAL MUCOSAL EXFOLIATION 5 0.0033
62 PRODUCT APPEARANCE CONFUSION 3 0.0032
63 BRADYKINESIA 19 0.0032
64 ALLERGY TO CHEMICALS 4 0.0032
65 SLEEP-RELATED EATING DISORDER 3 0.0032
66 OVARIAN DISORDER 3 0.0032
67 INFUSION SITE PRURITUS 10 0.0032
68 INFUSION SITE NODULE 3 0.0031
69 STOMA SITE INFECTION 4 0.0031
70 INFUSION SITE HAEMORRHAGE 10 0.0030
71 ILLUSION 5 0.0030
72 EYELID PAIN 6 0.0029
73 TYPE 2 DIABETES MELLITUS 99 0.0029
74 BEZOAR 4 0.0029
75 WAIST CIRCUMFERENCE INCREASED 3 0.0029
76 DEVICE CONNECTION ISSUE 6 0.0028
77 SLEEP DEFICIT 6 0.0028
78 HYPERKINESIA 6 0.0028
79 NASAL OEDEMA 5 0.0028
80 POST PROCEDURAL SWELLING 3 0.0027
81 DELUSION 42 0.0027
82 ESSENTIAL TREMOR 3 0.0027
83 MOUTH INJURY 4 0.0026
84 INFUSION SITE ERYTHEMA 22 0.0026
85 HYPORESPONSIVE TO STIMULI 3 0.0026
86 HYPERGLYCAEMIA 92 0.0025
87 PNEUMONIA INFLUENZAL 3 0.0025
88 HALLUCINATION, VISUAL 53 0.0025
89 POSTURE ABNORMAL 8 0.0025
90 BLADDER DISCOMFORT 3 0.0024
91 PERSECUTORY DELUSION 6 0.0024
92 EYE CONTUSION 5 0.0024
93 FEELINGS OF WORTHLESSNESS 3 0.0023
94 CEREBRAL ATROPHY 9 0.0023
95 ANIMAL BITE 6 0.0022
96 TEMPERATURE REGULATION DISORDER 5 0.0022
97 DEVICE ALARM ISSUE 4 0.0022
98 CARBON DIOXIDE INCREASED 3 0.0022
99 REACTION TO EXCIPIENT 5 0.0022
100 STOMA SITE ERYTHEMA 4 0.0021
101 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
102 ANIMAL SCRATCH 2 0.0021
103 PULMONARY PAIN 6 0.0021
104 HYPERPHAGIA 8 0.0020
105 ACQUIRED HAEMOPHILIA 2 0.0020
106 HALLUCINATION 149 0.0020
107 PSYCHOTIC SYMPTOM 4 0.0019
108 INFUSION SITE SWELLING 12 0.0019
109 ALLERGY TO ANIMAL 2 0.0019
110 MUSCLE RIGIDITY 22 0.0018
111 SHOULDER FRACTURE 3 0.0018
112 GASTROOESOPHAGEAL REFLUX DISEASE 141 0.0017
113 DYSKINESIA 71 0.0017
114 HAEMORRHOIDS 34 0.0017
115 INITIAL INSOMNIA 17 0.0017
116 DEVICE KINK 6 0.0016
117 INFUSION SITE PAIN 21 0.0016
118 SEASONAL ALLERGY 23 0.0016
119 PNEUMOPERITONEUM 3 0.0016
120 OBSESSIVE-COMPULSIVE DISORDER 13 0.0016
121 DEVICE INFUSION ISSUE 4 0.0016
122 BLOOD COUNT ABNORMAL 24 0.0016
123 PARKINSON'S DISEASE 4 0.0016
124 NASAL SEPTUM DEVIATION 3 0.0015
125 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
126 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
127 BLOOD POTASSIUM ABNORMAL 4 0.0015
128 ENURESIS 6 0.0015
129 SKIN ABRASION 7 0.0015
130 SKIN LACERATION 16 0.0015
131 CHEST INJURY 3 0.0014
132 AORTIC STENOSIS 5 0.0014
133 HYPERVOLAEMIA 7 0.0014
134 INFUSION SITE BRUISING 3 0.0014
135 SPUTUM INCREASED 3 0.0014
136 SPINAL OPERATION 17 0.0014
137 SPONDYLITIS 5 0.0014
138 ASTHMA 155 0.0014
139 SOMNAMBULISM 9 0.0014
140 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 3 0.0013
141 SNORING 5 0.0013
142 VASCULAR DEVICE INFECTION 6 0.0013
143 PARANASAL SINUS DISCOMFORT 5 0.0013
144 NONSPECIFIC REACTION 7 0.0013
145 MULTIPLE ALLERGIES 10 0.0013
146 CHOKING SENSATION 7 0.0013
147 HEART RATE ABNORMAL 7 0.0013
148 FOREIGN BODY SENSATION IN EYES 8 0.0013
149 SKIN EROSION 4 0.0012
150 PSYCHIATRIC SYMPTOM 9 0.0012
151 ACUTE PSYCHOSIS 3 0.0012
152 SPINAL COMPRESSION FRACTURE 10 0.0012
153 PLANTAR FASCIITIS 4 0.0012
154 DECREASED INTEREST 7 0.0012
155 INTERVERTEBRAL DISC DISORDER 5 0.0012
156 DRUG TITRATION ERROR 3 0.0012
157 PARANOIA 20 0.0012
158 CATHETER SITE PAIN 3 0.0012
159 PERSONALITY DISORDER 3 0.0011
160 DEPRESSIVE SYMPTOM 4 0.0011
161 SHOULDER ARTHROPLASTY 3 0.0011
162 HAEMOGLOBIN INCREASED 5 0.0011
163 SYNOVIAL CYST 5 0.0011
164 HYPERSOMNIA 31 0.0011
165 HALLUCINATION, AUDITORY 17 0.0011
166 IMPULSIVE BEHAVIOUR 4 0.0011
167 CHRONIC SINUSITIS 4 0.0011
168 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 18 0.0011
169 HYPERTONIC BLADDER 3 0.0010
170 UPPER RESPIRATORY TRACT CONGESTION 3 0.0010
171 DYSPNOEA AT REST 3 0.0010
172 REHABILITATION THERAPY 4 0.0010
173 FAECES HARD 4 0.0010
174 DEVICE POWER SOURCE ISSUE 3 0.0010
175 IMPAIRED GASTRIC EMPTYING 14 0.0010
176 LUMBAR SPINAL STENOSIS 3 0.0010
177 ORAL INFECTION 4 0.0010
178 SKIN LESION 28 0.0010
179 METABOLIC ENCEPHALOPATHY 3 0.0010
180 TOOTH ABSCESS 10 0.0010
181 DECUBITUS ULCER 8 0.0010
182 NERVE COMPRESSION 9 0.0010
183 SPINAL STENOSIS 4 0.0010
184 MIDDLE INSOMNIA 18 0.0010
185 MAJOR DEPRESSION 7 0.0010
186 FOOD CRAVING 5 0.0009
187 INTENTIONAL DOSE OMISSION 27 0.0009
188 INCONTINENCE 10 0.0009
189 AORTIC VALVE INCOMPETENCE 4 0.0009
190 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
191 POOR PERIPHERAL CIRCULATION 4 0.0009
192 ABSCESS LIMB 4 0.0009
193 PURULENT DISCHARGE 4 0.0009
194 SHOULDER OPERATION 4 0.0009
195 INCOHERENT 6 0.0009
196 IMMOBILE 4 0.0009
197 HOSPICE CARE 9 0.0009
198 WALKING AID USER 6 0.0009
199 POSTOPERATIVE WOUND INFECTION 6 0.0009
200 PERIORBITAL SWELLING 5 0.0009
201 LIMB INJURY 24 0.0009
202 BALANCE DISORDER 76 0.0009
203 LUMBAR VERTEBRAL FRACTURE 4 0.0009
204 EYE PAIN 49 0.0009
205 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
206 HYPOPNOEA 3 0.0009
207 NEPHROGENIC ANAEMIA 4 0.0009
208 ORTHOSTATIC HYPOTENSION 15 0.0009
209 WEIGHT FLUCTUATION 9 0.0009
210 FEELING OF DESPAIR 4 0.0009
211 DEVICE OCCLUSION 12 0.0009
212 SPINAL COLUMN STENOSIS 4 0.0008
213 SPUTUM DISCOLOURED 8 0.0008
214 SLEEP APNOEA SYNDROME 16 0.0008
215 NASAL CONGESTION 49 0.0008
216 FACIAL BONES FRACTURE 3 0.0008
217 PHARYNGITIS STREPTOCOCCAL 9 0.0008
218 MENISCUS INJURY 5 0.0008
219 ALCOHOL USE 3 0.0008
220 DIABETIC NEUROPATHY 4 0.0008
221 THINKING ABNORMAL 15 0.0008
222 PRE-EXISTING CONDITION IMPROVED 5 0.0008
223 OXYGEN SATURATION DECREASED 45 0.0008
224 JOINT INJURY 17 0.0008
225 POOR QUALITY SLEEP 17 0.0008
226 THERAPEUTIC RESPONSE CHANGED 5 0.0008
227 DEMENTIA 22 0.0008
228 PARANASAL SINUS HYPERSECRETION 3 0.0008
229 MOTOR DYSFUNCTION 8 0.0008
230 FACIAL PAIN 7 0.0008
231 PRODUCT COLOUR ISSUE 4 0.0008
232 CONCUSSION 6 0.0008
233 HIATUS HERNIA 10 0.0008
234 PELVIC FRACTURE 6 0.0008
235 MUSCLE RUPTURE 3 0.0008
236 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 37 0.0008
237 RESTLESSNESS 28 0.0008
238 SKIN ODOUR ABNORMAL 3 0.0008
239 PNEUMONIA FUNGAL 3 0.0008
240 JOINT DISLOCATION 8 0.0008
241 PRODUCT DISTRIBUTION ISSUE 7 0.0008
242 OBSTRUCTION 3 0.0008
243 RETCHING 16 0.0007
244 SPINAL FRACTURE 15 0.0007
245 ALCOHOL ABUSE 2 0.0007
246 RECTAL HAEMORRHAGE 32 0.0007
247 SKIN HAEMORRHAGE 11 0.0007
248 BIPOLAR DISORDER 8 0.0007
249 TRIGGER FINGER 3 0.0007
250 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
251 DROOLING 5 0.0007
252 THERAPEUTIC RESPONSE SHORTENED 24 0.0007
253 DENTAL CARIES 8 0.0007
254 LYMPHOEDEMA 5 0.0007
255 SUICIDAL BEHAVIOUR 3 0.0007
256 NERVE INJURY 8 0.0007
257 INSURANCE ISSUE 11 0.0007
258 FORMICATION 5 0.0007
259 PARKINSONISM 7 0.0007
260 KNEE OPERATION 7 0.0007
261 LIGAMENT SPRAIN 7 0.0007
262 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
263 HAND FRACTURE 5 0.0007
264 LOCALISED INFECTION 17 0.0007
265 DERMATITIS CONTACT 8 0.0007
266 CARDIAC VALVE DISEASE 4 0.0007
267 TENSION HEADACHE 3 0.0007
268 HYPOTHERMIA 7 0.0007
269 RESPIRATORY TRACT INFECTION 18 0.0007
270 TONGUE DISORDER 5 0.0007
271 DYSPNOEA EXERTIONAL 26 0.0007
272 DISTURBANCE IN ATTENTION 37 0.0007
273 ONYCHOMYCOSIS 3 0.0007
274 SPINAL OSTEOARTHRITIS 6 0.0007
275 TOOTH INFECTION 9 0.0007
276 GINGIVAL SWELLING 3 0.0007
277 ABDOMINAL ABSCESS 3 0.0007
278 ENERGY INCREASED 4 0.0007
279 SEROTONIN SYNDROME 13 0.0007
280 CATHETERISATION CARDIAC 3 0.0007
281 NEUROLEPTIC MALIGNANT SYNDROME 8 0.0007
282 SINUS HEADACHE 4 0.0007
283 CARDIOTOXICITY 6 0.0007
284 ANAL INCONTINENCE 6 0.0007
285 FALL 222 0.0007
286 SLEEP DISORDER 47 0.0007
287 KNEE ARTHROPLASTY 14 0.0007
288 KIDNEY INFECTION 13 0.0007
289 IMMUNE THROMBOCYTOPENIA 3 0.0007
290 HIP ARTHROPLASTY 10 0.0007
291 HEREDITARY ANGIOEDEMA 7 0.0007
292 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
293 GENERALISED OEDEMA 8 0.0006
294 ANKLE FRACTURE 10 0.0006
295 SCOLIOSIS 4 0.0006
296 BACK INJURY 7 0.0006
297 PERFORMANCE STATUS DECREASED 3 0.0006
298 INFUSION SITE EXTRAVASATION 4 0.0006
299 TIBIA FRACTURE 3 0.0006
300 ASPIRATION 7 0.0006
301 TORSADE DE POINTES 5 0.0006
302 BRONCHITIS 47 0.0006
303 ILLNESS 65 0.0006
304 RENAL CYST 5 0.0006
305 RESPIRATORY TRACT CONGESTION 10 0.0006
306 PRODUCTIVE COUGH 30 0.0006
307 SCREAMING 4 0.0006
308 LIMB OPERATION 3 0.0006
309 BLOOD PRESSURE FLUCTUATION 15 0.0006
310 DEPRESSED MOOD 33 0.0006
311 RASH VESICULAR 3 0.0006
312 EYE INFECTION 7 0.0006
313 MENTAL IMPAIRMENT 15 0.0006
314 DIZZINESS POSTURAL 6 0.0006
315 AUTOIMMUNE DISORDER 6 0.0006
316 URINARY TRACT INFECTION 105 0.0006
317 CHOLECYSTECTOMY 7 0.0006
318 PSYCHOTIC DISORDER 18 0.0006
319 FLUID RETENTION 31 0.0006
320 GASTROENTERITIS VIRAL 11 0.0006
321 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
322 PRODUCT FORMULATION ISSUE 4 0.0006
323 FOOT OPERATION 3 0.0006
324 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
325 SOMNOLENCE 122 0.0006
326 DELIRIUM 21 0.0006
327 BLADDER DISORDER 6 0.0006
328 PROTEIN URINE PRESENT 3 0.0006
329 SALIVARY HYPERSECRETION 6 0.0006
330 FLUID INTAKE REDUCED 3 0.0006
331 QUALITY OF LIFE DECREASED 8 0.0006
332 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
333 OSTEOPENIA 9 0.0006
334 DRUG TOLERANCE 3 0.0006
335 DYSPHORIA 3 0.0006
336 PRODUCT LABEL ISSUE 4 0.0006
337 DRUG DELIVERY SYSTEM MALFUNCTION 3 0.0006
338 MOBILITY DECREASED 42 0.0006
339 RIB FRACTURE 12 0.0006
340 CARDIAC OPERATION 5 0.0006
341 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
342 ABNORMAL BEHAVIOUR 23 0.0006
343 TREMOR 96 0.0006
344 MUSCLE STRAIN 5 0.0006
345 EYE DISCHARGE 6 0.0006
346 NOCTURIA 7 0.0006
347 BRAIN FOG 9 0.0006
348 PRODUCT ODOUR ABNORMAL 6 0.0006
349 SPEECH DISORDER 30 0.0006
350 CATATONIA 3 0.0006
351 DYSTONIA 11 0.0006
352 RENAL PAIN 6 0.0006
353 HEAD DISCOMFORT 10 0.0006
354 ATRIAL FIBRILLATION 55 0.0006
355 PNEUMONIA ASPIRATION 14 0.0006
356 SECRETION DISCHARGE 7 0.0006
357 SUBDURAL HAEMATOMA 8 0.0006
358 INJECTION SITE DISCHARGE 3 0.0006
359 PRODUCT RESIDUE PRESENT 3 0.0006
360 SINUS DISORDER 11 0.0006
361 BEHAVIOUR DISORDER 3 0.0006
362 HIP SURGERY 3 0.0006
363 BACK DISORDER 9 0.0006
364 BLOOD PRESSURE ABNORMAL 11 0.0006
365 DYSSTASIA 16 0.0005
366 WOUND INFECTION 6 0.0005
367 PRODUCT DOSE OMISSION ISSUE 161 0.0005
368 GASTROINTESTINAL PAIN 6 0.0005
369 ROTATOR CUFF SYNDROME 7 0.0005
370 GAIT DISTURBANCE 104 0.0005
371 OEDEMA PERIPHERAL 66 0.0005
372 DEPRESSION 123 0.0005
373 FIBROMYALGIA 13 0.0005
374 PRODUCT LEAKAGE 3 0.0005
375 PHOTOPHOBIA 10 0.0005
376 BLOOD SODIUM DECREASED 10 0.0005
377 PERONEAL NERVE PALSY 3 0.0005
378 SPINAL DISORDER 5 0.0005
379 MICTURITION URGENCY 6 0.0005
380 MIGRAINE 50 0.0005
381 INCREASED APPETITE 10 0.0005
382 LIPASE INCREASED 4 0.0005
383 SHOCK 12 0.0005
384 SKIN ATROPHY 3 0.0005
385 POST PROCEDURAL COMPLICATION 10 0.0005
386 GLAUCOMA 10 0.0005
387 CHRONIC KIDNEY DISEASE 39 0.0005
388 VITAMIN D DEFICIENCY 5 0.0005
389 HEART RATE DECREASED 18 0.0005
390 ORAL HERPES 10 0.0005
391 URINE ODOUR ABNORMAL 3 0.0005
392 COELIAC DISEASE 5 0.0005
393 PRODUCT USE COMPLAINT 8 0.0005
394 TACHYCARDIA 45 0.0005
395 DISABILITY 10 0.0005
396 BLOOD IRON DECREASED 6 0.0005
397 HEAD INJURY 16 0.0005
398 WEIGHT DECREASED 141 0.0005
399 INSOMNIA 134 0.0005
400 CYSTITIS 16 0.0005
401 UPPER LIMB FRACTURE 10 0.0005
402 SCIATICA 8 0.0005
403 HAEMATOMA 13 0.0005
404 CONFUSIONAL STATE 81 0.0005
405 WITHDRAWAL SYNDROME 21 0.0005
406 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
407 SINUSITIS 51 0.0005
408 PAIN IN JAW 14 0.0005
409 MUSCLE TIGHTNESS 8 0.0005
410 TENSION 3 0.0005
411 DRY THROAT 5 0.0005
412 POST PROCEDURAL INFECTION 4 0.0005
413 EAR INFECTION 13 0.0005
414 IMPAIRED QUALITY OF LIFE 7 0.0005
415 PERIPHERAL SWELLING 75 0.0005
416 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
417 ASTHENIA 182 0.0005
418 POOR VENOUS ACCESS 5 0.0005
419 HYPOKINESIA 7 0.0005
420 COUGH 135 0.0005
421 MEMORY IMPAIRMENT 66 0.0005
422 PETECHIAE 5 0.0005
423 NASAL DRYNESS 3 0.0005
424 MUSCLE TWITCHING 11 0.0005
425 FOOT FRACTURE 9 0.0005
426 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
427 ABNORMAL DREAMS 13 0.0005
428 MOVEMENT DISORDER 15 0.0005
429 PSEUDOMONAS INFECTION 4 0.0005
430 HAEMOGLOBIN ABNORMAL 3 0.0005
431 MUSCULOSKELETAL DISCOMFORT 8 0.0005
432 ECONOMIC PROBLEM 7 0.0005
433 HYSTERECTOMY 4 0.0005
434 CHOKING 9 0.0005
435 SKIN SWELLING 4 0.0005
436 SKIN FISSURES 9 0.0005
437 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
438 BRADYPHRENIA 3 0.0005
439 PRODUCT PREPARATION ISSUE 3 0.0005
440 CONTUSION 44 0.0005
441 EYE SWELLING 17 0.0005
442 COVID-19 80 0.0005
443 ORAL CANDIDIASIS 6 0.0005
444 DYSGRAPHIA 3 0.0005
445 COLD SWEAT 8 0.0005
446 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
447 BACK PAIN 105 0.0005
448 DYSARTHRIA 17 0.0005
449 BLOOD PRESSURE DECREASED 30 0.0005
450 MEDICATION ERROR 25 0.0004
451 TOOTH DISORDER 10 0.0004
452 EYE HAEMORRHAGE 6 0.0004
453 BASAL CELL CARCINOMA 7 0.0004
454 CARDIAC FAILURE CONGESTIVE 36 0.0004
455 MALIGNANT MELANOMA 6 0.0004
456 POST-TRAUMATIC STRESS DISORDER 3 0.0004
457 COLITIS ISCHAEMIC 3 0.0004
458 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
459 DYSPHONIA 26 0.0004
460 SURGERY 26 0.0004
461 HEART RATE IRREGULAR 10 0.0004
462 NEUROPATHY PERIPHERAL 42 0.0004
463 PNEUMOTHORAX 7 0.0004
464 ABDOMINAL HERNIA 2 0.0004
465 LOSS OF CONSCIOUSNESS 56 0.0004
466 CELLULITIS 22 0.0004
467 JOINT EFFUSION 3 0.0004
468 GASTRIC HAEMORRHAGE 5 0.0004
469 DIVERTICULITIS 12 0.0004
470 BLOOD POTASSIUM DECREASED 13 0.0004
471 ORAL DISCOMFORT 6 0.0004
472 ARTHRITIS INFECTIVE 2 0.0004
473 HUNGER 6 0.0004
474 LACRIMATION INCREASED 13 0.0004
475 APHONIA 6 0.0004
476 RASH MACULAR 15 0.0004
477 HEPATIC ENCEPHALOPATHY 4 0.0004
478 HYPONATRAEMIA 24 0.0004
479 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
480 COVID-19 PNEUMONIA 5 0.0004
481 THROAT IRRITATION 19 0.0004
482 DIALYSIS 6 0.0004
483 THERAPY NON-RESPONDER 19 0.0004
484 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
485 DYSPHAGIA 40 0.0004
486 VIRAL INFECTION 14 0.0004
487 MUSCULOSKELETAL DISORDER 8 0.0004
488 GAIT INABILITY 14 0.0004
489 HYPERLIPIDAEMIA 5 0.0004
490 PRODUCT SUBSTITUTION ISSUE 24 0.0004
491 AFFECT LABILITY 4 0.0004
492 PANIC REACTION 3 0.0004
493 AMNESIA 27 0.0004
494 PRODUCT DISPENSING ERROR 9 0.0004
495 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
496 ADVERSE DRUG REACTION 37 0.0004
497 ACCIDENTAL OVERDOSE 15 0.0004
498 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
499 RENAL DISORDER 19 0.0004
500 POLLAKIURIA 17 0.0004
501 COGNITIVE DISORDER 19 0.0004
502 BLINDNESS TRANSIENT 3 0.0004
503 URINARY INCONTINENCE 12 0.0004
504 FEELING ABNORMAL 97 0.0004
505 TOOTH EXTRACTION 5 0.0004
506 SNEEZING 9 0.0004
507 AGGRESSION 20 0.0004
508 PAROSMIA 3 0.0004
509 PEMPHIGOID 3 0.0004
510 PROCEDURAL PAIN 11 0.0004
511 MENTAL STATUS CHANGES 11 0.0004
512 FEEDING DISORDER 8 0.0004
513 DRUG DISPENSING ERROR 6 0.0004
514 AMMONIA INCREASED 2 0.0004
515 CONDITION AGGRAVATED 119 0.0004
516 DEVICE DISLOCATION 17 0.0004
517 NEUTROPHIL COUNT INCREASED 4 0.0004
518 FUNGAL INFECTION 13 0.0004
519 SYNCOPE 39 0.0004
520 PERICARDIAL EFFUSION 9 0.0004
521 OROPHARYNGEAL PAIN 36 0.0004
522 FOOD ALLERGY 3 0.0004
523 MUSCULOSKELETAL STIFFNESS 34 0.0004
524 ATRIOVENTRICULAR BLOCK 3 0.0004
525 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
526 UNRESPONSIVE TO STIMULI 10 0.0004
527 RHINORRHOEA 25 0.0004
528 CRYING 14 0.0004
529 DIPLOPIA 10 0.0004
530 TENDERNESS 4 0.0004
531 SUICIDAL IDEATION 35 0.0004
532 DYSURIA 14 0.0004
533 DRUG SCREEN POSITIVE 3 0.0004
534 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
535 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
536 DISORIENTATION 15 0.0004
537 SUDDEN DEATH 4 0.0004
538 PRODUCT USE ISSUE 71 0.0004
539 BREAST PAIN 4 0.0004
540 HIP FRACTURE 12 0.0004
541 STENT PLACEMENT 3 0.0004
542 MYASTHENIA GRAVIS 3 0.0004
543 FRUSTRATION TOLERANCE DECREASED 3 0.0004
544 SINUS CONGESTION 5 0.0004
545 DEHYDRATION 49 0.0004
546 AKATHISIA 5 0.0004
547 POLYURIA 3 0.0004
548 BLOOD PRESSURE INCREASED 56 0.0004
549 CORONARY ARTERY OCCLUSION 5 0.0004
550 FLUSHING 37 0.0004
551 CARDIAC DISORDER 34 0.0004
552 PHOTOSENSITIVITY REACTION 6 0.0004
553 TOOTH FRACTURE 4 0.0004
554 THERAPEUTIC RESPONSE DECREASED 22 0.0004
555 SUICIDE ATTEMPT 22 0.0004
556 CONSTIPATION 79 0.0004
557 MUSCLE INJURY 3 0.0004
558 VERTIGO 22 0.0004
559 EPISTAXIS 27 0.0004
560 EAR PAIN 7 0.0004
561 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
562 FEELING COLD 10 0.0004
563 OCULAR HYPERAEMIA 17 0.0004
564 WOUND 10 0.0004
565 ANGIOPATHY 2 0.0004
566 PANIC ATTACK 13 0.0004
567 SKIN INFECTION 4 0.0004
568 OCULAR DISCOMFORT 4 0.0004
569 CANDIDA INFECTION 6 0.0004
570 WHEEZING 21 0.0004
571 PRODUCT AVAILABILITY ISSUE 8 0.0004
572 BRONCHOSPASM 5 0.0004
573 HYPERSENSITIVITY 65 0.0003
574 PRODUCT CONTAINER ISSUE 3 0.0003
575 DYSPNOEA 198 0.0003
576 HYPERHIDROSIS 45 0.0003
577 MYOCARDITIS 4 0.0003
578 NEPHROLITHIASIS 16 0.0003
579 BLOOD MAGNESIUM DECREASED 3 0.0003
580 EXPOSURE VIA SKIN CONTACT 9 0.0003
581 DIZZINESS 173 0.0003
582 NIGHTMARE 12 0.0003
583 ABDOMINAL DISCOMFORT 58 0.0003
584 ANXIETY 98 0.0003
585 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
586 MUSCLE SPASMS 63 0.0003
587 URINE OUTPUT DECREASED 3 0.0003
588 CHEST DISCOMFORT 35 0.0003
589 FATIGUE 266 0.0003
590 GROIN PAIN 3 0.0003
591 IMMUNOSUPPRESSION 3 0.0003
592 LUNG INFILTRATION 3 0.0003
593 PURPURA 3 0.0003
594 PNEUMONIA 109 0.0003
595 WRONG DRUG ADMINISTERED 3 0.0003
596 NAUSEA 266 0.0003
597 DECREASED APPETITE 78 0.0003
598 MACULAR DEGENERATION 4 0.0003
599 WEIGHT INCREASED 75 0.0003
600 HAEMARTHROSIS 3 0.0003
601 FEAR 9 0.0003
602 GOUT 6 0.0003
603 WRIST FRACTURE 4 0.0003
604 OROPHARYNGEAL DISCOMFORT 3 0.0003
605 HYPOAESTHESIA ORAL 5 0.0003
606 ARTHRITIS 26 0.0003
607 UNEVALUABLE EVENT 25 0.0003
608 HYPOTENSION 66 0.0003
609 EATING DISORDER 7 0.0003
610 UROSEPSIS 3 0.0003
611 SKIN CANCER 7 0.0003
612 SMALL INTESTINAL OBSTRUCTION 4 0.0003
613 THYROID DISORDER 5 0.0003
614 HAEMOPTYSIS 9 0.0003
615 ILEUS 4 0.0003
616 DIARRHOEA HAEMORRHAGIC 3 0.0003
617 THERAPY PARTIAL RESPONDER 5 0.0003
618 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
619 CATARACT 19 0.0003
620 PAIN IN EXTREMITY 94 0.0003
621 ARTERIOSCLEROSIS 3 0.0003
622 SQUAMOUS CELL CARCINOMA 3 0.0003
623 INTESTINAL OBSTRUCTION 12 0.0003
624 RENAL FAILURE 42 0.0003
625 BLOOD URINE PRESENT 6 0.0003
626 GASTRIC ULCER 6 0.0003
627 CHILLS 37 0.0003
628 DIABETES MELLITUS 24 0.0003
629 INJECTION SITE IRRITATION 4 0.0003
630 INFLUENZA 35 0.0003
631 OEDEMA 17 0.0003
632 PULMONARY FIBROSIS 6 0.0003
633 HYPOXIA 11 0.0003
634 MYDRIASIS 4 0.0003
635 ROAD TRAFFIC ACCIDENT 13 0.0003
636 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 56 0.0003
637 NIGHT SWEATS 10 0.0003
638 APPLICATION SITE VESICLES 2 0.0003
639 DRY MOUTH 25 0.0003
640 BLOOD POTASSIUM INCREASED 5 0.0003
641 PHARYNGEAL SWELLING 3 0.0003
642 LUNG DISORDER 15 0.0003
643 HOSPITALISATION 47 0.0003
644 HEPATOMEGALY 3 0.0003
645 THERAPY CHANGE 3 0.0003
646 MULTIPLE FRACTURES 5 0.0003
647 NECK PAIN 17 0.0003
648 MANIA 5 0.0003
649 IMMUNE SYSTEM DISORDER 4 0.0003
650 STAPHYLOCOCCAL INFECTION 10 0.0003
651 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
652 APPETITE DISORDER 2 0.0003
653 DRY EYE 15 0.0003
654 MUSCULAR WEAKNESS 34 0.0003
655 HAIR TEXTURE ABNORMAL 4 0.0003
656 EYE PRURITUS 10 0.0003
657 EMPHYSEMA 3 0.0003
658 CHEST PAIN 55 0.0003
659 PRODUCT ADMINISTRATION ERROR 6 0.0003
660 MYALGIA 50 0.0003
661 THERAPY INTERRUPTED 21 0.0003
662 NASOPHARYNGITIS 54 0.0003
663 SCAR 5 0.0003
664 OSTEOPOROSIS 12 0.0003
665 TEMPERATURE INTOLERANCE 3 0.0003
666 PRODUCT USE IN UNAPPROVED INDICATION 72 0.0003
667 GASTROINTESTINAL DISORDER 26 0.0003
668 ARTHRALGIA 120 0.0003
669 PRESYNCOPE 7 0.0003
670 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
671 CARPAL TUNNEL SYNDROME 4 0.0003
672 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
673 ABASIA 7 0.0003
674 MALAISE 124 0.0003
675 IRRITABILITY 17 0.0003
676 HEART RATE INCREASED 28 0.0003
677 VISUAL IMPAIRMENT 35 0.0003
678 DRUG ERUPTION 5 0.0003
679 HEADACHE 176 0.0003
680 BODY HEIGHT DECREASED 3 0.0003
681 IRRITABLE BOWEL SYNDROME 6 0.0003
682 DEVICE ISSUE 25 0.0003
683 HYPOACUSIS 12 0.0003
684 VOMITING 131 0.0003
685 DECREASED ACTIVITY 3 0.0003
686 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
687 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
688 COMPLETED SUICIDE 23 0.0003
689 PRURITUS 106 0.0003
690 PULMONARY THROMBOSIS 3 0.0003
691 OESOPHAGITIS 3 0.0003
692 TREATMENT NONCOMPLIANCE 15 0.0003
693 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
694 SKIN ULCER 7 0.0003
695 FOOT DEFORMITY 3 0.0003
696 ARTHROPOD BITE 2 0.0003
697 PULMONARY MASS 4 0.0003
698 MALNUTRITION 3 0.0003
699 BACTERIAL INFECTION 5 0.0003
700 DEAFNESS 7 0.0003
701 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
702 BLOOD CALCIUM DECREASED 3 0.0003
703 ANHEDONIA 7 0.0003
704 GASTRITIS 7 0.0003
705 APHASIA 8 0.0003
706 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
707 CORONARY ARTERY DISEASE 8 0.0003
708 FRACTURE 5 0.0003
709 IMPAIRED DRIVING ABILITY 3 0.0003
710 COLITIS 10 0.0003
711 AORTIC ANEURYSM 2 0.0003
712 HAEMATURIA 9 0.0003
713 INTERNAL HAEMORRHAGE 3 0.0003
714 FEELING JITTERY 5 0.0003
715 LETHARGY 15 0.0003
716 EYE IRRITATION 15 0.0003
717 UNINTENTIONAL MEDICAL DEVICE REMOVAL 3 0.0003
718 AGITATION 19 0.0003
719 HERNIA 5 0.0003
720 LIMB DISCOMFORT 8 0.0003
721 MUSCULOSKELETAL CHEST PAIN 4 0.0003
722 DRUG INTERACTION 41 0.0003
723 TENDONITIS 4 0.0003
724 FEMUR FRACTURE 8 0.0003
725 BURNING SENSATION 18 0.0003
726 SPLENOMEGALY 3 0.0003
727 SPINAL PAIN 3 0.0003
728 PAIN 157 0.0003
729 LYMPHADENOPATHY 9 0.0003
730 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
731 MENTAL DISORDER 11 0.0003
732 CEREBRAL HAEMORRHAGE 9 0.0003
733 ACCIDENT 3 0.0003
734 OBESITY 4 0.0003
735 MULTIPLE SCLEROSIS 12 0.0003
736 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
737 NEURALGIA 6 0.0002
738 TASTE DISORDER 5 0.0002
739 DEVICE BREAKAGE 10 0.0002
740 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
741 ABNORMAL FAECES 2 0.0002
742 PRODUCT PREPARATION ERROR 5 0.0002
743 INJECTION SITE EXTRAVASATION 3 0.0002
744 ABNORMAL WEIGHT GAIN 3 0.0002
745 SEPSIS 27 0.0002
746 DIARRHOEA 155 0.0002
747 PULMONARY HYPERTENSION 5 0.0002
748 ABDOMINAL DISTENSION 25 0.0002
749 TINNITUS 11 0.0002
750 CARDIO-RESPIRATORY ARREST 10 0.0002
751 BLOOD UREA INCREASED 4 0.0002
752 HOT FLUSH 18 0.0002
753 BRAIN OEDEMA 3 0.0002
754 MOUTH ULCERATION 5 0.0002
755 CARDIAC FAILURE 19 0.0002
756 OSTEOARTHRITIS 10 0.0002
757 RESPIRATORY DISORDER 7 0.0002
758 ARTHROPATHY 13 0.0002
759 HYPOAESTHESIA 35 0.0002
760 HYPERTENSION 49 0.0002
761 INFLUENZA LIKE ILLNESS 19 0.0002
762 PRODUCT PRESCRIBING ISSUE 5 0.0002
763 SEDATION 6 0.0002
764 DEVICE USE ISSUE 4 0.0002
765 FEELING HOT 14 0.0002
766 BEDRIDDEN 3 0.0002
767 VISION BLURRED 31 0.0002
768 SWELLING 21 0.0002
769 THIRST 4 0.0002
770 THROMBOSIS 18 0.0002
771 JOINT RANGE OF MOTION DECREASED 3 0.0002
772 ORAL PAIN 5 0.0002
773 FREQUENT BOWEL MOVEMENTS 6 0.0002
774 PALPITATIONS 26 0.0002
775 RASH PRURITIC 12 0.0002
776 GINGIVAL BLEEDING 3 0.0002
777 END STAGE RENAL DISEASE 4 0.0002
778 HYPOTHYROIDISM 7 0.0002
779 PERIPHERAL COLDNESS 3 0.0002
780 ACUTE KIDNEY INJURY 33 0.0002
781 JOINT SWELLING 26 0.0002
782 AGRANULOCYTOSIS 4 0.0002
783 COORDINATION ABNORMAL 3 0.0002
784 HEPATIC STEATOSIS 4 0.0002
785 BLOOD CHOLESTEROL INCREASED 10 0.0002
786 THERAPY CESSATION 11 0.0002
787 APPENDICITIS 2 0.0002
788 ILL-DEFINED DISORDER 13 0.0002
789 DYSPEPSIA 21 0.0002
790 TARDIVE DYSKINESIA 6 0.0002
791 VISUAL ACUITY REDUCED 7 0.0002
792 ECZEMA 11 0.0002
793 RED BLOOD CELL COUNT DECREASED 6 0.0002
794 PARALYSIS 3 0.0002
795 RASH ERYTHEMATOUS 10 0.0002
796 URTICARIA 35 0.0002
797 BLOOD GLUCOSE DECREASED 10 0.0002
798 LOWER LIMB FRACTURE 4 0.0002
799 PARAESTHESIA ORAL 3 0.0002
800 ACUTE RESPIRATORY FAILURE 4 0.0002
801 SEIZURE 24 0.0002
802 INFECTION 30 0.0002
803 GASTROENTERITIS 3 0.0002
804 HAEMOGLOBIN DECREASED 21 0.0002
805 LABORATORY TEST ABNORMAL 6 0.0002
806 ABDOMINAL PAIN 47 0.0002
807 SKIN EXFOLIATION 17 0.0002
808 IMMUNODEFICIENCY 3 0.0002
809 PULMONARY OEDEMA 9 0.0002
810 DEEP VEIN THROMBOSIS 13 0.0002
811 INTENTIONAL SELF-INJURY 4 0.0002
812 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40 0.0002
813 INCORRECT DOSE ADMINISTERED 45 0.0002
814 PARAESTHESIA 31 0.0002
815 BODY TEMPERATURE INCREASED 4 0.0002
816 SKIN DISCOLOURATION 9 0.0002
817 HYPOPHAGIA 5 0.0002
818 INJECTION SITE RASH 6 0.0002
819 RASH 85 0.0002
820 DEVICE RELATED INFECTION 3 0.0002
821 TOOTH LOSS 4 0.0002
822 C-REACTIVE PROTEIN INCREASED 7 0.0002
823 UNDERDOSE 14 0.0002
824 HERPES ZOSTER 11 0.0002
825 JOINT STIFFNESS 5 0.0002
826 DRUG INEFFECTIVE 250 0.0002
827 ABDOMINAL PAIN UPPER 39 0.0002
828 ULCER 3 0.0002
829 DYSGEUSIA 14 0.0002
830 MOOD SWINGS 6 0.0002
831 INJECTION SITE BRUISING 15 0.0002
832 BONE PAIN 11 0.0002
833 DRY SKIN 25 0.0002
834 DRUG EFFECT DECREASED 10 0.0002
835 THROAT TIGHTNESS 5 0.0002
836 PNEUMONITIS 5 0.0002
837 CHOLELITHIASIS 6 0.0002
838 EYE DISORDER 6 0.0002
839 VENTRICULAR TACHYCARDIA 3 0.0002
840 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
841 COAGULOPATHY 3 0.0002
842 HEPATOTOXICITY 4 0.0002
843 INJECTION SITE PAIN 55 0.0002
844 INJECTION SITE PRURITUS 12 0.0002
845 ANAEMIA 34 0.0002
846 CHROMATURIA 4 0.0002
847 HEMIPARESIS 3 0.0002
848 CEREBROVASCULAR ACCIDENT 30 0.0002
849 FLATULENCE 10 0.0002
850 CIRCULATORY COLLAPSE 3 0.0002
851 DRUG INTOLERANCE 17 0.0002
852 INFLAMMATION 9 0.0002
853 SYRINGE ISSUE 3 0.0002
854 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
855 ASCITES 5 0.0002
856 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
857 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
858 RENAL INJURY 5 0.0002
859 DRUG ABUSE 14 0.0002
860 ALOPECIA 33 0.0002
861 COMA 8 0.0002
862 INFUSION RELATED REACTION 11 0.0002
863 OSTEOMYELITIS 3 0.0002
864 STOMATITIS 10 0.0002
865 NEOPLASM MALIGNANT 11 0.0002
866 RESPIRATORY FAILURE 12 0.0002
867 PLEURAL EFFUSION 10 0.0002
868 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
869 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
870 ADVERSE EVENT 15 0.0002
871 EMOTIONAL DISORDER 5 0.0002
872 DEVICE LEAKAGE 7 0.0002
873 ERYTHEMA 33 0.0002
874 BLISTER 9 0.0002
875 DRUG WITHDRAWAL SYNDROME 14 0.0002
876 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
877 HAEMATEMESIS 4 0.0002
878 INJECTION SITE SWELLING 12 0.0002
879 INTENTIONAL OVERDOSE 10 0.0002
880 PRESCRIBED OVERDOSE 3 0.0002
881 MYOCARDIAL INFARCTION 27 0.0002
882 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
883 INJECTION SITE ERYTHEMA 19 0.0002
884 NERVOUSNESS 8 0.0002
885 PANCREATITIS 8 0.0002
886 ADVERSE REACTION 2 0.0002
887 LIP SWELLING 5 0.0001
888 SKIN DISORDER 5 0.0001
889 FULL BLOOD COUNT DECREASED 3 0.0001
890 ANGER 5 0.0001
891 ARRHYTHMIA 7 0.0001
892 DISCOMFORT 9 0.0001
893 HEPATIC ENZYME INCREASED 10 0.0001
894 MOOD ALTERED 4 0.0001
895 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
896 HYPOGLYCAEMIA 7 0.0001
897 DEVICE USE ERROR 5 0.0001
898 DERMATITIS 3 0.0001
899 RENAL IMPAIRMENT 12 0.0001
900 OFF LABEL USE 125 0.0001
901 RENAL FAILURE ACUTE 6 0.0001
902 PLATELET COUNT DECREASED 15 0.0001
903 ANGINA PECTORIS 4 0.0001
904 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
905 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
906 APATHY 2 0.0001
907 MELAENA 3 0.0001
908 GLOSSODYNIA 3 0.0001
909 HEPATIC FUNCTION ABNORMAL 5 0.0001
910 BLOOD GLUCOSE INCREASED 25 0.0001
911 BRADYCARDIA 7 0.0001
912 INJECTION SITE REACTION 9 0.0001
913 DEVICE MALFUNCTION 9 0.0001
914 SWOLLEN TONGUE 4 0.0001
915 INJURY 9 0.0001
916 PYREXIA 44 0.0001
917 INTENTIONAL PRODUCT MISUSE 11 0.0001
918 DEATH 108 0.0001
919 ABSCESS 2 0.0001
920 BLOOD CREATININE INCREASED 8 0.0001
921 INJECTION SITE URTICARIA 3 0.0001
922 ENCEPHALOPATHY 3 0.0001
923 IMPAIRED HEALING 4 0.0001
924 NO ADVERSE EVENT 22 0.0001
925 OSTEONECROSIS OF JAW 3 0.0001
926 DEVICE DIFFICULT TO USE 8 0.0001
927 AGEUSIA 3 0.0001
928 URINARY RETENTION 4 0.0001
929 PRODUCT COMPLAINT 3 0.0001
930 PRODUCT QUALITY ISSUE 16 0.0001
931 HEPATITIS 3 0.0001
932 ERECTILE DYSFUNCTION 3 0.0001
933 GASTRIC DISORDER 4 0.0001
934 HYPERKALAEMIA 4 0.0001
935 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
936 OVERDOSE 24 0.0001
937 PALLOR 3 0.0001
938 SWELLING FACE 7 0.0001
939 PSORIASIS 14 0.0001
940 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
941 ACNE 8 0.0001
942 HAEMORRHAGE 11 0.0001
943 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
944 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
945 DISEASE PROGRESSION 12 0.0001
946 PSORIATIC ARTHROPATHY 4 0.0001
947 THROMBOCYTOPENIA 11 0.0001
948 BLINDNESS 4 0.0001
949 LUNG NEOPLASM MALIGNANT 4 0.0001
950 GYNAECOMASTIA 3 0.0001
951 RHEUMATOID ARTHRITIS 11 0.0001
952 DRUG DOSE OMISSION 16 0.0001
953 RHABDOMYOLYSIS 4 0.0001
954 MUSCULOSKELETAL PAIN 5 0.0001
955 TOXICITY TO VARIOUS AGENTS 16 0.0001
956 PULMONARY EMBOLISM 9 0.0001
957 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
958 OSTEONECROSIS 3 0.0001
959 EMOTIONAL DISTRESS 11 0.0001
960 ANAPHYLACTIC REACTION 5 0.0001
961 LIVER DISORDER 4 0.0001
962 INJECTION SITE HAEMORRHAGE 7 0.0001
963 CONVULSION 5 0.0001
964 HYPOKALAEMIA 4 0.0001
965 CARDIAC ARREST 7 0.0001
966 PRODUCT ADHESION ISSUE 3 0.0001
967 DRUG EFFECT INCOMPLETE 3 0.0001
968 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
969 INJECTION SITE MASS 3 0.0001
970 ABDOMINAL PAIN LOWER 2 0.0001
971 PRODUCT DOSE OMISSION 5 0.0001
972 APPLICATION SITE ERYTHEMA 2 0.0001
973 DERMATITIS ATOPIC 4 0.0001
974 EXTRA DOSE ADMINISTERED 3 0.0001
975 DEPENDENCE 4 0.0001
976 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
977 SEPTIC SHOCK 3 0.0001
978 ACUTE MYOCARDIAL INFARCTION 2 0.0001
979 COLITIS ULCERATIVE 3 0.0001
980 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
981 RENAL CANCER 3 0.0001
982 TREATMENT FAILURE 5 0.0001
983 PRODUCT STORAGE ERROR 5 0.0001
984 SKIN BURNING SENSATION 4 0.0001
985 HAEMATOCHEZIA 3 0.0001
986 NEUTROPENIA 7 0.0001
987 DRUG DEPENDENCE 8 0.0000
988 PROSTATE CANCER 4 0.0000
989 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
990 BREAST CANCER 3 0.0000